Combined loss of expression of O6-methylguanine-DNA methyltransferase and hMLH1 accelerates progression of hepatocellular carcinoma

Journal of Surgical Oncology

Volumn 82, Issue 3, 2003, Pages 194-200

  Matsukura, Shiroh ^a   Miyazaki, Kohji ^a   Yakushiji, Hiroyuki ^a   Ogawa, Akiomi ^a   Chen, Yongxin ^a   Sekiguchi, Mutsuo ^b  

^a SAGA UNIVERSITY   (Japan)

^b FUKUOKA DENTAL COLLEGE   (Japan)

Author keywords

Hepatocellular carcinoma; Human Mut L homologue 1 (hMLH1); Immunohistochemistry; O6 methylguanine DNA methyltransferase (MGMT); Prognosis

Indexed keywords

METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN MLH1;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CLINICAL ARTICLE; CORRELATION ANALYSIS; DNA REPAIR; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MALE; MALIGNANT TRANSFORMATION; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STAINING; SURVIVAL RATE; TUMOR GROWTH;

AGED; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; DISEASE PROGRESSION; DNA REPAIR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; NUCLEAR PROTEINS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; PROGNOSIS;

EID: 0037374586     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.10209     Document Type: Article

References (43)

1. Okuda K: Hepatocellular carcinoma: Recent progress. Hepatology 1992;15:948-963.
2. Okuda K: Hepatocellular carcinoma. J Hepatol 2000;32:225-237.
3. 6-alkylguanine-DNA alkyltransferase: Regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res 1990;50:6119-6129.
4. 6-alkylguanine-DNA alkyltransferase activity based on cellular DNA content in human, rat and mouse tissues. Carcinogenesis 1986;7:745-749.
5. 6 alkylguanine-DNA alkyltransferase gene in normal human liver tissues as revealed by in situ hybridization. Carcinogenesis 1993;14:737-741.
6. Iwakuma T, Sakumi K, Nakatsuru Y, et al.: High incidence of nitrosamine-induced tumorigenesis in mice lacking DNA repair methyltransferase. Carcinogenesis 1997;18:1631-1635.
7. 6-methylguanine-DNA methyltransferase in hepatocellular, gastric, and breast cancers. Ann Surg Oncol 2001;8:807-816.
8. Lahue RS, Au KG, Modrich P: DNA mismatch correction in a defined system. Science 1989;245:160-164.
9. Fishel R, Lescoe MK, Rao MRS, et al.: The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993;75:1027-1038.
10. Leach FS, Nicolaides NC, Papadopoulos N, et al.: Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993;75:1215-1225.
11. Papadopoulos N, Nicolaides NC, Wei YF, et al.: Mutation of a mutL homolog in hereditary colon cancer. Science 1994;263:1625-1629.
12. Kang GH, Shim YH, Ro JY: Correlation of methylation of the hMLH1 promoter with lack of expression of hMLH1 in sporadic gastric carcinomas with replication error. Lab Invest 1999;79:903-909.
13. Yamamoto H, Perez-Piteira J, Yoshida T, et al.: Gastric cancers of the microsatellite mutator phenotype display characteristic genetic and clinical features. Gastroenterology 1999;116:1348-1357.
14. Kawate H, Sakumi K, Tsuzuki T, et al.: Separation of killing and tumorigenic effects of an alkylating agent in mice defective in two of the DNA repair genes. Proc Natl Acad Sci USA 1998;95:5116-5120.
15. Branch P, Aquilina G, Bignami M. et al.: Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage. Nature 1993;362:652-654.
16. Kat A, Thilly WG, Fang WH, et al.: An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair. Proc Natl Acad Sci USA 1993;90:6424-6428.
17. 6-methylguanine-DNA methyltransferase combined with mismatch repair proteins hMLH1 and hMSH2 are related to poor prognosis in human biliary tract carcinoma. Ann Surg Oncol 2002;9:371-379.
18. Sobin LH, Wittekind C, (eds): "UICC TNM Classification of Malignant Tumors." 5th ed. Berlin: Springer; 1997.
19. Wang L, Banbi-Hani A, Montoya DP, et al.: hMLH1 and hMSH2 expression in human hepatocellular carcinoma. Int J Oncol 2001;19:567-570.
20. 6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res 2000;60:2368-2371.
21. 6-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutation in p53 in human colorectal tumorigenesis. Cancer Res 2001;61:4689-4692.
22. Esteller M, Garcia-Foncillas J, Andion E, et al.: Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 2000;343:1350-1354.
23. Hayashi H, Sugio K, Matsumata T, et al.: The clinical significance of p53 gene mutation in hepatocellular carcinoma from Japan. Hepatology 1995;22:1702-1707.
24. Yano M, Asahara T, Dohi K, et al.: Close correlation between a p53 or hMSH2 gene mutation in the tumor and survival of hepatocellular carcinoma patients. Int J Oncol 1999;14:447-451.
25. Jeng KS, Sheen IS, Chen BF, et al.: Is the p53 gene mutation of prognostic value in hepatocellular carcinoma after resection ? Arch Surg 2000;135:1329-1333.
26. Wani Y, Notohara K, Tsukayama C, et al.: Reduced expression of hMLH1 and hMSH2 gene products in high-grade hepatocellular carcinoma. Acta Med Okayama 2001;55:65-71.
27. Yamamoto H, Itoh F, Fukushima H, et al.: Infrequent widespread microsatellite instability in hepatocellular carcinomas. Int J Oncol 2000;16:543-547.
28. Saeki A, Tamura S, Ito N, et al.: Lack of frameshift mutations at coding mononucleotide repeats in hepatocellular carcinoma in Japanese patients. Cancer 2000;88:1025-1029.
29. Macdonald GA, Greenson JK, Saito K, et al.: Microsatellite instability and loss of heterozygosity at DNA mismatch repair gene loci occurs during hepatic carcinogenesis. Hepatology 1998; 28:90-97.
30. Kondo Y, Kanai Y, Sakamoto M, et al.: Microsatellite instability associated with hepatocarcinogenesis. J Hepatol 1999;31: 529-356.
31. Day RS III, Ziolkowski CHJ, Scudiero DA, et al.: Defective repair of alkylated DNA by human tumour and SV40-transformed human cell strains. Nature 1980;288:725-727.
32. - human tumor cells. Cancer Res 1990;50:7908-7911.
33. - human tumor cell lines containing the MGMT gene by the polymerase chain reaction technique. Cancer Commun 1990;2:13-20.
34. 6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 1999;59:793-797.
35. 6-methylguanine-DNA methyltransferase gene by transcriptional coactivators cAMP response element-binding protein-binding protein and p300. J Biol Chem 2000;44:34197-34204.
36. 6-methylguanine-DNA methyltransferase promoter region as a marker of gene silencing. Mol Carcinogen 1999;24:85-89.
37. Herfarth KK-F, Brent TP, Danam RP, et al.: A specific CpG methylation pattern of the MGMT promoter region associated with reduced MGMT expression in primary colorectal cancers. Mol Carcinogen 1999;24:90-98.
38. Esteller M, Corn PG, Baylin SB, et al.: A gene hypermethylation profile of human cancer. Cancer Res 2001;61:3225-3229.
39. Kanai Y, Ushijima S, Hui AM, et al.: The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int J Cancer 1997;71:355-359.
40. Kanai Y, Hui AM, Sun L, et al.: DNA hypermethylation at the D17S5 locus and reduced HIC-1 mRNA expression are associated with hepatocarcinogenesis. Hepatology 1999;29:703-709.
41. Tchou JC, Lin X, Freije D, et al.: GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas. Int J Oncol 2000; 16:663-676.
42. Wong IHN, Dennis Lo YM, Yeo W, et al.: Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients. Clin Cancer Res 2000;6: 3516-3521.
43. INK4A gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus. Gut 2001;48: 372-377.